Notizia - Recent Pharma, Healthcare and Biotech Happenings

Strategic Immunology Alliance partners Nimbus Therapeutics and Celgene to develop therapies for Autoimmune Disorders A biotechnology company involved in the development of drugs and therapies through computational expertise announced on October 3 that they are entering into a long-term strategic alliance with Celgene Corporation in the therapy area of immunology. The terms of the agreement will help Celgene use the option to acquire each program in the alliance up through a clinical inflection point. In turn, Nimbus will receive an upfront payment and potential downstream milestone payments for each program Celgene chooses to acquire. As for the R&D activities, Nim...